ClinicalTrials.gov
ClinicalTrials.gov Menu

Hemophilia B Gene Therapy With AAV8 Vector

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01620801
Recruitment Status : Terminated
First Posted : June 15, 2012
Last Update Posted : April 17, 2018
Sponsor:
Collaborators:
Children's Hospital of Philadelphia
University of Pittsburgh
Royal Prince Alfred Hospital, Sydney, Australia
St. James's Hospital, Ireland
Information provided by (Responsible Party):
Spark Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : March 2016
  Actual Study Completion Date : March 2016